Back to Journals Therapeutics and Clinical Risk Management Volume 10 Safety and efficacy of acarbose in the treatment of diabetes in Chinese patients Received 21 April 2014 Accepted for publication 4 June 2014 Published 30 June 2014 Volume 2014:10 Pages 505511 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Ke He*, Jun-Cheng Shi*, Xiao-Ming Mao Department of Endocrinology, Nanjing First Hospital Affiliated to Nanjing Medical University, Nanjing, People's Republic of China *These authors contributed equally to this work Abstract: Acarbose is an -glucosidase inhibitor that is commonly used to control postprandial blood glucose
Epithalon is primarily recognized for its potential role in the modulation of telomerase activity, a key enzyme involved in the maintenance and elongation of telomeres
By combining the right medication with nutrition optimization, consistent physical activity, adequate sleep, and stress management, most people can achieve meaningful, sustainable weight loss
This means faster, more effective healing when you need it most
This keeps all titration and maintenance doses within the range of a standard 100-unit insulin syringe
Neurosci Bull